{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:59:26Z","timestamp":1758045566211,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004071","name":"Khon Kaen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.amjms.2021.05.027","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T02:56:51Z","timestamp":1622602611000},"page":"570-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study)"],"prefix":"10.1016","volume":"362","author":[{"given":"Burabha","family":"Pussadhamma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajanee","family":"Mahakkanukrauh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siraphop","family":"Suwannaroj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratanavadee","family":"Nanagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chingching","family":"Foocharoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2021.05.027_bib0001","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2021.05.027_bib0002","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjms.2021.05.027_bib0003","first-page":"656","article-title":"A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma)","volume":"17","author":"Follansbee","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2021.05.027_bib0004","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/rheumatology\/kev096","article-title":"Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report)","volume":"54","author":"Foocharoen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjms.2021.05.027_bib0005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s100670050071","article-title":"Cardiac involvement in limited systemic sclerosis: non-invasive assessment in asymptomatic patients","volume":"18","author":"Handa","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.amjms.2021.05.027_bib0006","first-page":"S48","article-title":"Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin","volume":"28","author":"Allanore","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.amjms.2021.05.027_bib0007","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10067-013-2405-1","article-title":"Abnormal cardiac enzymes in systemic sclerosis: a report of four patients and review of the literature","volume":"33","author":"Vasta","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.amjms.2021.05.027_bib0008","first-page":"581","article-title":"Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjms.2021.05.027_bib0009","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol"},{"key":"10.1016\/j.amjms.2021.05.027_bib0010","first-page":"483","article-title":"Sudden arrhythmia death syndrome: importance of the long QT syndrome","volume":"68","author":"Meyer","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.amjms.2021.05.027_bib0011","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.amjms.2021.05.027_bib0012","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.amjms.2021.05.027_bib0013","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.amjmed.2011.10.031","article-title":"Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain","volume":"125","author":"Irfan","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.amjms.2021.05.027_bib0014","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jacc.2013.03.055","article-title":"Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy","volume":"62","author":"Kubo","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.amjms.2021.05.027_bib0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00392-007-0526-8","article-title":"Pulmonary hypertension: current diagnosis and treatment","volume":"96","author":"Rosenkranz","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjms.2021.05.027_bib0016","first-page":"53","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.amjms.2021.05.027_bib0017","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s10067-011-1744-z","article-title":"Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients","volume":"30","author":"Foocharoen","year":"2011","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.amjms.2021.05.027_bib0018","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/eurjhf\/hfp198","article-title":"Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study","volume":"12","author":"Mizuno","year":"2010","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.amjms.2021.05.027_bib0019","first-page":"183","article-title":"Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement","volume":"42","author":"Nakajima","year":"2001","journal-title":"J. Nucl. Med"},{"key":"10.1016\/j.amjms.2021.05.027_bib0020","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/rheumatology\/35.10.983","article-title":"Left ventricular function in scleroderma","volume":"35","author":"Armstrong","year":"1996","journal-title":"Br. J. Rheumatol"},{"key":"10.1016\/j.amjms.2021.05.027_bib0021","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1054\/jcaf.2003.51","article-title":"Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study","volume":"9","author":"Fernandes","year":"2003","journal-title":"J. Card. Fail"},{"key":"10.1016\/j.amjms.2021.05.027_bib0022","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2018.07.068","article-title":"Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis","volume":"72","author":"Tenn\u00f8e","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.amjms.2021.05.027_bib0023","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s10067-013-2307-2","article-title":"Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature","volume":"32","author":"Yang","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.amjms.2021.05.027_bib0024","first-page":"38","article-title":"Predictive ability of tricuspid regurgitation velocity for pulmonary hypertension in patients with systemic sclerosis; an experience from Srinagarind Hospital","volume":"5","author":"Pussadhamma","year":"2019","journal-title":"KKU Med J"},{"key":"10.1016\/j.amjms.2021.05.027_bib0025","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/acr.22547","article-title":"Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide","volume":"67","author":"Avouac","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.amjms.2021.05.027_bib0026","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/BOR.0b013e32834b8975","article-title":"Systemic sclerosis and the heart: current diagnosis and management","volume":"23","author":"Desai","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.amjms.2021.05.027_bib0027","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4330\/wjc.v6.i9.993","article-title":"Cardiac manifestations in systemic sclerosis","volume":"6","author":"Lambova","year":"2014","journal-title":"World J Cardiol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921002135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921002135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:39:55Z","timestamp":1757702395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921002135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0002962921002135"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2021.05.027","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2021.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}